Atorvastatin attenuates cardiac hypertrophy through AMPK/miR-143-3p/Bcl2 axis

Anti-hypertrophy effect of atorvastatin on myocardium depends on AMPK activation-induced miR-143-3p suppression via Foxo1

(2018) Bo Yu et al.   BIOMEDICINE & PHARMACOTHERAPY

Inhibition of microRNA-143-3p attenuates myocardial hypertrophy by inhibiting inflammatory response

(2018) Bo Yu et al.   CELL BIOLOGY INTERNATIONAL

Atorvastatin inhibits miR-143 expression: A protective mechanism against oxidative stress in cardiomyocytes

(2016) Shanshan Tian et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism

(2016) Karla Reichert et al.   PLoS One

Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy

(2015) Jian Guo et al.   EUROPEAN HEART JOURNAL

The failing human heart is characterized by decreased numbers of telocytes as result of apoptosis and altered extracellular matrix composition

(2015) Manfred Richter et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

MicroRNA-22 Downregulation by Atorvastatin in a Mouse Model of Cardiac Hypertrophy: a new Mechanism for Antihypertrophic Intervention

(2013) Yingfeng Tu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Magnetic Resonance Imaging Left Ventricular Mass Reduction With Fixed-Dose Angiotensin-Converting Enzyme Inhibitor–Based Regimens in Patients With High-Risk Hypertension

(2009) Nathaniel Reichek et al.   HYPERTENSION